Type: Blog
… Intervention (PCI)Percutaneous coronary intervention—or PCI—is a nonsurgical procedure performed in the catheterization … inflated at the blockage site in the artery to flatten or compress the plaque against the artery wallDuring a stent … … PCI vs Protected PCI What is the Difference and Which One is Right for Me …
Type: Press Release
… and improved survival and native heart recovery as compared to inconsistent treatment or inexperienced … and effective in the US for cardiogenic shock less than one year ago which has allowed us to collaborate with … registry data (cVAD) and IDE approved FDA studies The points reflected specifically in the IQ Database as compared …
Type: Press Release
… WIRE)--Oct 26 2020-- The United States Food and Drug Administration (FDA) has granted Abiomed (NASDAQ ABMD) a 510(k) clearance for an all-in-one compact cardiopulmonary bypass system called the Abiomed …
Type: Press Release
… of the RESTORE EF study demonstrate Impella-supported high-risk percutaneous coronary intervention (PCI) leads to … best practices in contemporary PCI practice including more complete revascularization Participants received an … high-risk PCI also called an “on-pump PCI” at one of 22 sites across the United States between August 2019 …
Type: Press Release
… fiscal 2020 revenue of $2050 million an increase of 13% compared to revenue of $1818 million for the same period of … growth rate by $3 million in revenue or approximately two points of growth Outside the US revenue totaled $330 million … 31 2019 through 1100 am EST on November 7 2019 The replay phone number is (855) 859-2056 the international number is …
Type: Press Release
… ABOUT ABIOMED Based in Danvers Massachusetts Abiomed Inc is a leading provider of medical devices that provide … the heart For additional information please visit wwwabiomedcom FORWARD-LOOKING STATEMENTS This release contains … recently filed Annual Report on Form 10-K Readers are cautioned not to place undue reliance on any forward-looking …
Type: Press Release
… 2019-- Abiomed (NASDAQABMD) will highlight the benefits of complete revascularization with Protected PCI and the value … Cardiovascular Therapeutics (TCT) conference in San Francisco from September 25-29 During the conference Abiomed will … RevascularizationThursday September 26630-745 am PDTMoscone South Level 2 Room 205-206Chair William O’Neill …
Type: Press Release
… Completed Enrollment for the FDA STEMI DTU Safety and … and support technologies today reported first quarter fiscal 2019 revenue of $1800 million an increase of 36% … 26 2018 through 1100 am ET on August 2 2018 The replay phone number is (855) 859-2056 the international number is …
Type: Press Release
… heart support technologies today reported fourth quarter fiscal 2017 revenue of $1247 million an increase of 33% compared to revenue of $940 million for the same period of … share impacted by $31 million or $007 per diluted share of one-time items described below For the full fiscal year GAAP …
Type: Press Release
… (NASDAQABMD) announced that on Thursday February 4 2016 the Company will release financial results for the third quarter of fiscal 2016 The Company will host a conference call to … 4 2016 through 1159 pm EST on February 6 2016 The replay phone number is (855) 859-2056 the international number is …